These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30761303)

  • 61. Elements of renal injury in patients with erysipelas.
    Velciov S; Gluhovschi G; Feier V; Curescu M; Trandafirescu V; Petrică L; Gluhovschi C; Bob F; Bozdog G; Gadalean F; Florescu C; Bobu M; Chiliban A
    Rom J Intern Med; 2010; 48(2):179-85. PubMed ID: 21428183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recurrent erysipelas--risk factors and clinical presentation.
    Inghammar M; Rasmussen M; Linder A
    BMC Infect Dis; 2014 May; 14():270. PubMed ID: 24884840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment.
    Casey JR; Kahn R; Gmoser D; Atlas E; Urbani K; Luber S; Pellman H; Pichichero ME
    Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Juvenile relapsing periarteritis nodosa and streptococcal infection.
    Tonnelier JM; Ansart S; Tilly-Gentric A; Pennec YL
    Joint Bone Spine; 2000; 67(4):346-8. PubMed ID: 10963087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment.
    Pichichero ME
    Ann Emerg Med; 1995 Mar; 25(3):390-403. PubMed ID: 7864482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategies for managing group A streptococcal pharyngitis. A survey of board-certified pediatricians.
    Hofer C; Binns HJ; Tanz RR
    Arch Pediatr Adolesc Med; 1997 Aug; 151(8):824-9. PubMed ID: 9265886
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recurrent erysipelas: risk factors.
    Pavlotsky F; Amrani S; Trau H
    J Dtsch Dermatol Ges; 2004 Feb; 2(2):89-95. PubMed ID: 16279242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
    Krasagakis K; Samonis G; Maniatakis P; Georgala S; Tosca A
    Dermatology; 2006; 212(1):31-5. PubMed ID: 16319471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Streptococcal infections--updated.
    Wannamaker LW; Ferrieri P
    Dis Mon; 1975 Oct; ():1-40. PubMed ID: 810336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.
    Ferreira A; Bolland MJ; Thomas MG
    Infection; 2016 Oct; 44(5):607-15. PubMed ID: 27085865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors associated with acute and recurrent erysipelas in a young population: a retrospective of 147 cases.
    Chamli A; Jaber K; Ben Lagha I; Ben Slimane M; Rabhi F; Doss N; Dhaoui MR
    Tunis Med; 2021 Aout; 99(8):886-889. PubMed ID: 35261016
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibiotic prophylaxis for preventing recurrent cellulitis: a systematic review and meta-analysis.
    Oh CC; Ko HC; Lee HY; Safdar N; Maki DG; Chlebicki MP
    J Infect; 2014 Jul; 69(1):26-34. PubMed ID: 24576824
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment.
    Sunderkötter C; Becker K
    J Dtsch Dermatol Ges; 2015 Jun; 13(6):501-24; quiz 525-6. PubMed ID: 26018361
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atypical erysipelas caused by group G streptococci in a patient with cured Hodgkin's disease.
    Shama S; Calandra GB
    Arch Dermatol; 1982 Nov; 118(11):934-6. PubMed ID: 7138055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Erysipelas and lymphedema--egg or hen?].
    Stöberl C; Partsch H
    Z Hautkr; 1987 Jan; 62(1):56-62. PubMed ID: 3577282
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Erysipelas].
    Oehler E; Porteu-Barbedet S
    Rev Prat; 2017 Nov; 67(9):991-996. PubMed ID: 30516910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antibiotic treatment for prevention of infectious complications in joint replacement].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Apr; 73(2):108-14. PubMed ID: 16735008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Erysipelas after breast cancer treatment].
    Ben Salah H; Siala W; Maaloul I; Bouzid F; Frikha M; Daoud J
    Tunis Med; 2002 Aug; 80(8):465-8. PubMed ID: 12703126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.